<DOC>
	<DOCNO>NCT01514994</DOCNO>
	<brief_summary>The Valvuloplasty Scoring Balloon First-in-Man study prospective , single arm , two phase , observational registry demonstrate safety efficacy Valvuloplasty Scoring Balloon Catheter treatment critical aortic valve stenosis .</brief_summary>
	<brief_title>Valvuloplasty Scoring Balloon Catheter First-in-Man Study</brief_title>
	<detailed_description>Phase 1 enroll patient schedule undergo open surgical aortic valve replacement Valvuloplasty Scoring Balloon deliver stenotic aortic valve standard aortotomy deploy immediately prior valve replacement . Phase 2 enroll patient aortic valve stenosis deem suitable candidate elective surgical aortic valve replacement investigational Valvuloplasty Scoring Balloon use stand-alone Valvuloplasty procedure `` bridge '' trans-catheter aortic valve implantation ( TAVI ) surgery .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Native , degenerativecalcific , tricuspid , aortic valve stenosis echocardiographic derive criterion : mean gradient &gt; 40 mm Hg Doppler peak systolic velocity great 4.0 m/s initial aortic valve area &lt; 0.8 cm2 . Symptomatic aortic valve disease demonstrate CCS Functional Class II great Aortic valve annulus great equal 18 mm less equal 28 mm measure preprocedure TTE . Phase 1 patient must schedule surgical aortic valve replacement . Phase 2 patient must suitable candidate elective surgical aortic valve replacement . Recent myocardial infarction ( &lt; 30days ) Unicuspid bicuspid aortic valve noncalcific aortic valve stenosis Any sepsis , include active endocarditis Concomitant 2+ great aortic valve valve regurgitation LVEF &lt; 20 % CVA TIA within previous 6 month Previous aortic valve replacement ( bioprosthetic mechanical )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>